Aytu Biopharma (AYTU) Goodwill (2015 - 2022)

Aytu Biopharma (AYTU) has 7 years of Goodwill data on file, last reported at $8.6 million in Q1 2022.

• Goodwill for Q1 2022 came in at $8.6 million, down 77.1% year-over-year; the trailing twelve-month figure through Mar 2022 was $8.6 million (down 77.1% YoY), and the FY2021 annual result was $65.8 million, up 134.25% from the prior year.
• Goodwill eased to $8.6 million in Q1 2022 per AYTU's latest filing, from $46.3 million in the prior quarter.
• Over five years, Goodwill peaked at $65.8 million in Q2 2021 and troughed at $8.6 million in Q1 2022.
• A 4-year average of $32.9 million and a median of $28.1 million in 2020 frame the typical range for Goodwill.
• The sharpest annual moves came in 2021 and 2022: Goodwill surged 134.25% in 2021, then sank 77.1% in 2022.
• A 4-year view of Goodwill shows it stood at $15.4 million in 2019, then jumped by 82.56% to $28.1 million in 2020, then soared by 65.0% to $46.3 million in 2021, then plunged by 81.37% to $8.6 million in 2022.
• Business Quant data shows AYTU's Goodwill at $8.6 million in Q1 2022, $46.3 million in Q4 2021, and $46.3 million in Q3 2021.